tiprankstipranks
Trending News
More News >
Cosmo Bio Co., Ltd. (JP:3386)
:3386
Japanese Market
Advertisement

Cosmo Bio Co., Ltd. (3386) Income Statement

Compare
0 Followers

Cosmo Bio Co., Ltd. Income Statement

Last quarter (Q4 2024), Cosmo Bio Co., Ltd.'s total revenue was ¥2.63B, an increase of 6.70% from the same quarter last year. In Q4, Cosmo Bio Co., Ltd.'s net income was ¥-29.00M. See Cosmo Bio Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 10.04B¥ 9.34B¥ 9.55B¥ 9.23B¥ 8.09B
Gross Profit
¥ 3.33B¥ 3.25B¥ 3.44B¥ 3.66B¥ 3.15B
Operating Expenses
¥ 3.01B¥ 2.73B¥ 2.62B¥ 2.61B¥ 2.40B
Depreciation and Amortization
¥ 136.00M¥ 148.00M¥ 141.00M¥ 166.00M¥ 175.00M
EBITDA
¥ 455.00M¥ 669.00M¥ 958.00M¥ 1.22B¥ 928.00M
Operating Income
¥ 318.00M¥ 519.00M¥ 816.00M¥ 1.05B¥ 752.00M
Other Income/Expenses
¥ 51.00M¥ 134.00M¥ -26.00M¥ 51.00M¥ 256.00M
Pretax Income
¥ 369.00M¥ 653.00M¥ 790.00M¥ 1.10B¥ 1.01B
Net Income
¥ 262.00M¥ 442.00M¥ 517.00M¥ 737.00M¥ 674.00M
Per Share Metrics
Basic EPS
¥ 45.05¥ 75.83¥ 89.13¥ 126.94¥ 113.70
Diluted EPS
¥ 45.05¥ 75.83¥ 89.13¥ 126.94¥ 113.70
Weighted Average Shares Outstanding
5.82M 5.83M 5.81M 5.81M 5.93M
Weighted Average Shares Outstanding (Diluted)
5.82M 5.83M 5.81M 5.81M 5.93M
Currency in JPY

Cosmo Bio Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis